MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2022 International Congress

    Incidental Lewy Body disease and idiopathic Parkinson’s disease: from common pathogenic factors to the overlapping clinical features

    E. Sansa, T. Warner, E. Depablo Fernandez (London, United Kingdom)

    Objective: To compare established early symptoms and risk factors associated with Parkinson’s disease (PD) in a cohort of incidental Lewy Body disease (iLBD) and healthy…
  • 2022 International Congress

    COVID-19 impact on Anxiety, Depression, Stress, and Cortisol in Persons with Parkinson’s Disease

    B. Lobb, A. Hiller (Portland, USA)

    Objective: To assess psychological stress, through subjective and objective measures, in Parkinson’s disease (PD) prior to and during the worldwide pandemic. Background: We have had…
  • 2022 International Congress

    Striatal Subregion Analysis Associated with REM Sleep Behavior Disorder in Parkinson’s disease

    IH. Kwak, HI. Ma, YE. Kim, YJ. Kim (Anyang, Republic of Korea)

    Objective: Herein we evaluated the regional selectivity of presynaptic striatal dopaminergic denervation associated with RBD in drug-naive early PD. Background: REM sleep behavior disorder (RBD)…
  • 2022 International Congress

    Association between sleep apnea and prognosis in patients with multiple system atrophy

    S. Jo, S. Lee, J. Lee, SA. Lee, SJ. Chung (Seoul, Republic of Korea)

    Objective: We aimed to investigate the relationship between sleep apnea and survival or early frequent falls in patients with multiple system atrophy (MSA). Background: Sleep-disordered…
  • 2022 International Congress

    Painful arm spasms after remote electrical injury: focal epilepsy begets causalgia-dystonia?

    J. Cohen, J. Wilkinson (Philadelphia, USA)

    Objective: We describe a case of episodic, painful arm spasms with involuntary tremulous movements, after remote electrocution injury. Background: A variety of movement disorders have…
  • 2022 International Congress

    Availability and accessibility of medicines for patients with Parkinson’s disease in Kyrgyzstan

    C. Shambetova (Bishkek, Kyrgyzstan)

    Objective: The aim of the study was to assess the availability and accessibility of medicines for patients with Parkinson’s disease (PD) in Kyrgyzstan. Background: After…
  • 2022 International Congress

    IncobotulinumtoxinA for treating chronic sialorrhea due to Parkinson’s disease and other neurological conditions

    W. Jost, F. Pagan (Wolfach, Germany)

    Objective: To summarize clinical experience with incobotulinumtoxinA (INCO) for treating chronic sialorrhea due to Parkinson’s disease (PD), atypical parkinsonism, stroke, or traumatic brain injury in…
  • 2022 International Congress

    CLINICAL CHARACTERSITICS OF ESSENTIAL TREMOR PATIENTS THAT DEVELOPE PARKINSON´S DISEASE: A COHORT BASED STUDY.

    C. Borrue- Fernandez (San Sebastian Reyes, Spain)

    Objective: To elucidate the clinical characteristics of those patients previously diagnosed with essential tremor ( ET ) that finally developed a Parkinson´s disease during the follow…
  • 2022 International Congress

    Analyzing the metabolic function of DJ-1 in the pathogenesis of Parkinson`s disease (PD) and Glioblastoma multiforme (GBM)

    P. Mencke (Esch-sur-Alzette, Luxembourg)

    Objective: In this project, we are comprehensively studying the function of DJ-1 in PD and GBM to better understand its observed role in both, neurodegeneration…
  • 2022 International Congress

    Impact of ApoE genotype on cognition in idiopathic and genetic forms of Parkinson’s disease

    C. Koros, K. Brockmann, Aμ. Simitsi, A. Bougea, H. Liu, ακ. Hauser, C. Schulte, I. Pachi, N. Papagiannakis, A. Zahou, I. Wurster, E. Efthymiopoulou, I. Beratis, R. Antonelou, M. Maniati, M. Moraitou, H. Michelakakis, G. Paraskevas, S. Papageorgiou, C. Potagas, D. Papadimitriou, M. Bozi, M. Stamelou, T. Gasser, L. Stefanis (Athens, Greece)

    Objective: The aim of our current report was to assess the impact of Apolipoprotein-E (ApoE) genotype on cognition in idiopathic Parkinson’s disease (PD) patients and…
  • « Previous Page
  • 1
  • …
  • 84
  • 85
  • 86
  • 87
  • 88
  • …
  • 153
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • To be or not to bupropion: a drug-induced parkinsonism?
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
      • Help & Support
      • About Us
      • Cookies & Privacy
      • Wiley Job Network
      • Terms & Conditions
      • Advertisers & Agents
      Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
      Wiley